Sitagliptin (Januvia™) is a new oral agent ... including T-cell activation and proliferation. Although the mechanism of action may indicate that DPP-4 inhibition is a promising treatment for ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors, recently used in T2DM treatment, have a unique mechanism of action via inhibition of renal ... Dipeptidyl peptidase-4 inhibitors (DPP-4i s) include ...

In 2018, Merck was approved for unaccompanied use of the SGLT2 inhibitor ertugliflozin as well as combined with metformin and also in combination with the DPP-4 inhibitor sitagliptin ... Figure 1.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The question of putative mechanisms of action continues to haunt psychopharmacology. Put simply, we know these drugs work, but we have very little idea how. We make guesses based on the ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

Cameron Diaz is officially Back in Action! The Bad Teacher beauty, 52, hasn’t been seen in a movie since 2014’s Annie — so naturally, her return to movies is newsworthy. The blonde bombshell ...